Skip to main content

Table 7 Prevalence of entitlement to specially reimbursed medication for any disease and for selected chronic diseases

From: Inverse probability weighting and doubly robust methods in correcting the effects of non-response in the reimbursed medication and self-reported turnout estimates in the ATH survey

Subset

True

Crude§

95% CI*

SW#

95% CI

IPW†

95% CI*

DR‡

95% CI*

Diabetes

             

Continental Finland

6

7.6

6.5

8.7

6.6

5.6

7.6

6.2

5.2

7.2

6.4

5.6

7.1

Turku

4.6

6.7

6

7.5

5.9

5.1

6.7

5.4

4.6

6.2

5.3

4.8

5.8

Kainuu

6.6

8.9

8

9.7

7.3

6.5

8.1

6.8

6

7.5

6.7

6.2

7.3

Southern Oulu region

6.9

9.3

7.7

10.8

7.5

6.2

8.8

6.5

5.4

7.7

6.8

5.9

7.6

Oulu region

4.4

5.8

4.9

6.8

4.9

4.1

5.8

4.2

3.4

5

4.4

3.9

5

Men

6.7

7.2

6.6

7.7

8.2

6.7

9.8

5.1

4.5

5.7

7.3

6.9

7.8

Women

5.3

8.2

7.5

8.8

5.3

4.2

6.4

5.6

5

6.2

5.2

4.8

5.6

Age group 20-54

2.6

2.5

2.1

2.9

3.2

2.2

4.1

2.3

1.9

2.8

3.8

3.4

4.1

Age group 55-74

10.2

9.6

8.8

10.4

8.8

7

10.6

9.3

8.3

10.2

9.2

8.5

9.8

Age group 75-99

14.4

14.5

13.3

15.7

14.3

11.6

17.1

14

12.6

15.3

14.3

13.4

15.2

Other neurological diseases

Continental Finland

2.2

2.4

1.8

3.1

2

1.4

2.5

2

1.4

2.7

2

1.6

2.5

Turku

2

1.9

1.5

2.3

1.8

1.3

2.2

1.6

1.2

2.1

1.6

1.4

1.9

Kainuu

2.7

2.5

2.1

3

2.3

1.8

2.8

2.4

1.9

2.9

2.5

2.1

2.9

Southern Oulu region

2.3

2.4

1.6

3.2

2.1

1.4

2.9

2.1

1.3

2.8

2

1.5

2.5

Oulu region

2.3

2.6

2

3.3

2.3

1.7

2.9

2.3

1.6

2.9

2.3

1.9

2.8

Men

2.5

2.3

2

2.7

2.5

1.6

3.4

1.9

1.5

2.3

2.2

1.9

2.5

Women

1.9

2.4

2

2.7

1.6

1

2.2

2.2

1.8

2.6

1.8

1.6

2.1

Age group 20-54

1.6

1.5

1.2

1.8

1.4

0.7

2

1.5

1.2

1.9

1.6

1.4

1.8

Age group 55-74

2.6

2.6

2.2

3

1.9

1

2.7

2.6

2.1

3.1

1.9

1.6

2.2

Age group 75-99

4.5

3.6

2.9

4.2

5.3

3.5

7

4

3.2

4.8

5.2

4.6

5.8

Psychosis

             

Continental Finland

2.2

2

1.4

2.6

2

1.4

2.6

2.3

1.5

3.1

2.5

1.8

3.2

Turku

1.5

1.2

0.9

1.6

1.2

0.8

1.6

1.3

0.9

1.7

1.3

1

1.5

Kainuu

2.7

2.2

1.8

2.6

2.2

1.8

2.7

2.5

1.9

3.1

2.6

2.2

3.1

Southern Oulu region

2.8

2

1.3

2.7

2

1.2

2.7

1.9

1.2

2.6

1.9

1.4

2.5

Oulu region

1.9

1.1

0.7

1.5

1

0.6

1.4

1

0.6

1.5

1

0.7

1.3

Men

2.1

1.7

1.4

2

2.4

1.4

3.3

1.6

1.2

1.9

2.9

2.5

3.3

Women

2.3

1.7

1.4

2

1.7

1

2.3

1.6

1.2

1.9

1.6

1.4

1.8

Age group 20-54

1.8

1.5

1.2

1.8

1.9

1.1

2.6

1.4

1.1

1.8

2.2

1.9

2.4

Age group 55-74

2.7

1.9

1.5

2.3

2.1

1.1

3

1.7

1.3

2.1

2.4

2

2.7

Age group 75-99

3.1

1.9

1.4

2.4

1.9

0.9

3

2

1.4

2.6

2.1

1.7

2.5

Any entitlement to reimbursed medication

Continental Finland

31

40.9

38.9

42.9

35.8

33.9

37.8

32.7

30.7

34.7

32.9

31.5

34.3

Turku

26.3

35

33.5

36.4

31.8

30

33.5

27.8

26.1

29.4

27.8

26.9

28.7

Kainuu

39

49.7

48.2

51.1

43.5

41.9

45.1

40.6

39.1

42.2

40.1

39

41.1

Southern Oulu region

39.1

48.3

45.7

50.9

43

40.4

45.7

38.7

36.1

41.3

39.3

37.5

41.1

Oulu region

29.8

37.5

35.5

39.5

33.3

31.4

35.3

29

27.1

30.9

29.8

28.6

31

Men

29.6

41.9

40.7

43

38.3

35.5

41.1

31

29.7

32.3

32.7

31.9

33.5

Women

32.2

42.6

41.4

43.7

34.1

31.8

36.4

32

30.7

33.3

32.7

31.9

33.4

Age group 20-54

15.5

19

18

19.9

18.5

16.3

20.6

17.1

16

18.2

19.1

18.4

19.7

Age group 55-74

48.9

50

48.7

51.4

48.1

44.8

51.4

49.6

47.9

51.2

49.2

48.1

50.3

Age group 75-99

75.3

74.5

73

76

74.6

71.1

78

74.5

72.8

76.3

74.6

73.5

75.8

  1. *95% confidence intervals (CI).
  2. §Crude prevalences are based on participants without weighting.
  3. #Sampling weighted (SW) prevalence estimates are based on participants and sampling probabilities.
  4. †Inverse probability weighted (IPW) prevalence estimates are corrected for the nonresponse.
  5. ‡Doubly robust (DR) prevalence estimates are corrected for the nonresponse.
  6. True prevalences based on the full sample and sampling probabilities, and corresponding estimates based on participants and different statistical methods to account for missing data in continental Finland and in different subgroups.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us